Nasdaq-listed Alvotech, an Iceland-headquartered global biotech company specialising in biosimilars, has placed US$108m 6.875% senior unsecured convertible bonds due 2030. The initial conversion price is fixed at US$5.9224 per share,…
Iceland: Alvotech places US$108m convertible bonds to support development
…
…






